A randomized, double-blind, placebo controlled study of oral adenosine triphosphate in subacute low back pain

Journal of Rheumatology

Volumn 32, Issue 6, 2005, Pages 1114-1117

  Bannwarth, Bernard ^a,b   Allaert, François Andre ^c   Avouac, Bernard ^d   Rossignol, Michel ^e   Rozenberg, Sylvie ^f   Valat, Jean Pierre ^g  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Teaching Hospital   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e MCGILL UNIVERSITY   (Canada)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g SERVICE DE DERMATOLOGIE   (France)

Author keywords

Adenosine triphosphate; Low back pain; Pain

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATEPADENE; DEXTROPROPOXYPHENE; PARACETAMOL;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADENOSINE TRIPHOSPHATE; ADMINISTRATION, ORAL; ADULT; ANALGESICS; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOW BACK PAIN; MALE; PAIN MEASUREMENT; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 20444439920     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hick GS, Duddleston DN, Russell LD, Holman HE, Shepherd JM, Brown CA. Low back pain. Am J Med Sci 2002;324:207-11.
2. Pengel LHM, Herbert RD, Maher CG, Refshauge KM. Acute low back pain: systematic review of its prognosis. BMJ 2003;327:323-5.
3. Abenhaim L, Rossignol M, Valat JP, et al. The role of activity in the therapeutic management of back pain. Report of the International Paris Task Force on Back Pain. Spine 2000;25 Suppl:1S-33S.
4. Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about low back pain? JAMA 1992;268:760-5.
5. De Seze S. Randomized, double-blind, placebo-controlled trial of Atépadène® in back pain [French]. Gazette Médicale 1987;90:62-6.
6. Kichenin K, Seman M. Chronic oral administration of ATP modulates nucleoside transport and purine metabolism in rats. J Pharmacol Exp Ther 2000;294:126-33.
7. Kichenin K, Decollogne S, Angignard J, Seman M. Cardiovascular and pulmonary response to oral administration of ATP in rabbits. J Appl Physiol 2000;88:1962-8.
8. Van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the Cochrane collaboration. Spine 2003;28:1978-92.
9. Mathieu P, Richard M, Vignon E. Intramuscular diffusion and efficacy of Atépadène® in back pain [French]. Rhumatologie 1988;40:8.
10. Roland M, Morris R. A study of the natural history of low back pain: Part 1. Development of a reliable and sensitive measure of disability in low-back pain. Spine 1983;8:141-4.
11. Coste J, Le Pare JM, Berge E, Delecoeuillerie G, Paolaggi JB. Adaptation and validation in French of a disability rating scale for low back pain patients (the EIFEL questionnaire). Rev Rhum Engl Ed 1993;60:295-301.
12. Roland M, Fairbanck J. The Roland-Morris Disability Questionnaire and the Oswestry Disability Questionnaire. Spine 2000;25:3115-24.
13. Karjalainen K, Malwivaara A, Van Tulder M, et al. Multidisciplinary biopsychological rehabilitation for subacute low back pain among working age adults. Cochrane Database Syst Rev 2003(2):CD002193.
14. Bombardier C, Hayden J, Beaton DE. Minimally clinically important difference. Low back pain: outcome measures. J Rheumatol 2001;28:431-8.
15. Stratford PW, Binkley JM, Riddle DL, Guyatt GH. Sensitivity to change of the Roland-Morris Back Pain Questionnaire: part I. Phys Ther 1998;78:1186-96.